首页> 外文期刊>The Canadian journal of hospital pharmacy. >Subcutaneous Infusion of Pamidronate in a Hospice Patient with Hypercalcemia: A Case Report
【24h】

Subcutaneous Infusion of Pamidronate in a Hospice Patient with Hypercalcemia: A Case Report

机译:皮下注射在患有高钙血症的临终关怀患者中的pamidronate:案例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Hypercalcemia is a complication of cancer, reported to affect between 10% and 40% of patients with cancer and occurring in those with both solid tumours and hematologic malignancies.1-4 Cancer is the most common cause of hypercalcemia in the inpatient setting, most frequently breast, renal, and lung cancer and multiple myeloma.1,2,5 Malignancy is usually clinically evident by the time it causes hypercalcemia, and patients with hypercalcemia of malignancy often have a poor prognosis.
机译:高钙血症是癌症的一种并发症,据报道影响10%到40%的癌症患者,发生在实体瘤和血液系统恶性肿瘤患者中。1-4癌症是住院患者高钙血症的最常见原因,最常见的是乳腺癌、肾癌、肺癌和多发性骨髓瘤。1,2,5恶性肿瘤通常在引起高钙血症时临床表现明显,恶性肿瘤高钙血症患者通常预后不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号